SEC Form 4 · accession 0001179110-18-000826
HEALTHEQUITY, INC. · HQY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W Selander
Director
Period of report
Jan 8, 2018
Accepted (ET)
Jan 10, 2018 · 7:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001428336
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 8, 2018 | A | 10,748 | $0.00 | A | 11,748 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $21.27 | holding | — | — | — | — | Feb 1, 2026 | Common Stock | 15,000 | 15,000 | D |
| Stock Option (right to buy)F3 | $28.68 | holding | — | — | — | — | Sep 29, 2025 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1Includes 10,748 shares underlying restricted stock units previously reported on Table II. 4,175 shares of common stock underlying these restricted stock units previously reported on Table II were delivered on January 8, 2018. The remaining 6,573 shares of common stock underlying these restricted stock units previously reported on Table II will be delivered to the reporting person on January 18, 2019, unless such date does not occur during an "open window period," in which case the shares will be delivered promptly following the first day of the next "open window period."
- F2The option is immediately exercisable.
- F3The option is exercisable as to 25,000 shares. The remaining shares become exercisable in two equal installments of 12,500 shares on September 29, 2018 and 2019; provided that the reporting person continues to serve as a director of the issuer through such dates.
Remarks
The power of Attorney given by Mr. Selander was previously filed with the U.S. Securities & Exchange Commission on February 3, 2017 as an exhibit to a statement on Form 4 filed by Mr. Selander with respect to HealthEquity, Inc. and is hereby incorporated by reference.